miR-133b enhances CRC cells’ chemosensitivity to anti-tumor drugs 5-fluorouracil (5-FU) or vincristine (VCR) by directly downregulating ABCC1 [142]. The gene discussed is ABCC1; the disease is colorectal carcinoma.